2017 OPEN MINDS Strategy & Innovations Institute To Feature

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
285
2017 OPEN MINDS Strategy & Innovations Institute To Feature Innovation Collaborations With Key Thought Leaders In Health & Human Services

Gettysburg, PA, May 22, 2017 (GLOBE NEWSWIRE) -- OPEN MINDS announced opening keynotes and featured faculty for this year’s 2017 OPEN MINDS Strategy & Innovations Institute. Along with Jeff Reid, Enterprise Vice President of the Digital Center Of Excellence At Humana and Ian A. Shaffer, M.D., MMM, CPE, Vice President & Executive Medical Director Of Behavioral Health At Healthfirst, this event will feature a number of exciting faculty members from health and human services organizations. This information-packed two-day event will take place on June 6-7, 2017 at the Sheraton New Orleans Hotel (French Quarter), in New Orleans, Louisiana.

This year’s institute will feature innovative collaborations and productive partnerships with the payers, health systems, and care management organizations that are driving the value-based care market. This executive event is the only national gathering designed to help organizations serving complex consumers link emerging innovations to strategy to build successful, sustainable organizations.

The event will kick-off will a keynote address from Jeff Reid, Enterprise Vice President of the Digital Center of Excellence at Humana on, “Humana’s Digital Transformation: Redefining The Consumer Health Care Experience.” Mr. Reid is an executive leader in the continued evolution of digital at Humana, including the web, mobile, and social platforms. He is responsible for developing and executing Humana’s digital strategy by focusing on creating simple, connected, and personalized digital experiences that empower Humana’s members to achieve their best health.

Day two will kick-off will a keynote address from Ian A. Shaffer, M.D., MMM, CPE, Vice President and Executive Medical Director Of Behavioral Health At Healthfirst on, “Keys To Success With Integrated Care Models For Consumers With Complex Behavioral Disorders.” Dr. Shaffer is responsible for behavioral health program management at Healthfirst.

In addition to the keynote presentations, this year’s institute agenda will feature health and human service organizations that have successfully developed strategic alliances and innovative market solutions to gain the competitive advantage. Faculty will include OPEN MINDS senior team members, along with:

  • AJ Peterson, Vice President, Interoperability, Netsmart
  • Alan Rice, LCSW, Population Health Specialist, VNSNY CHOICE - Select Health HIV SNP
  • Allen Brown, Chief Executive Officer, Adult & Child Health
  • Alyssa Brown, J.D., Acting Deputy Director, Planning Administration, Maryland Office of Health Care Financing
  • Alyssa L. Rose, JD/MSW, Director, Network Strategy, Beacon Health Options
  • Amy Gallagher, Psy.D., Vice President, Whole Health, LLC, a subsidiary of Mind Springs Health
  • Anthony J. Mele, Psy.D., Chief Clinical Officer, Sovereign Health
  • Briana Gilmore, Director of Planning & Recovery Practice, Community Access
  • Candace Clevenger, Chief Executive Officer, Heritage Behavioral Health Center
  • Darryl Donlin, LCSW, MBA, Vice President of Network Operations, New Directions Behavioral Health
  • Fady Sahhar, Ph.D., President, XtraGlobex, Inc.
  • Harvey Rosenthal, Executive Director, New York Association of Psychiatric Rehabilitation Services
  • Heidi C. Waters, MBA, PhD, Director of Outcomes Management at Otsuka Pharmaceutical Development & Commercialization, Inc.
  • Ian Lang, Executive Director, Continuum Behavioral Health
  • Jennifer Garber, MA, LICSW, Director of Clinical Operations and Community Initiatives, Medica Behavioral Health
  • Joe Dan Beavers, CPA, MHA, President/CEO, LifeSkills, Inc.
  • Lori A. Accardi, LMSW, Executive Director, Encompass Health Home & Catholic Charities of Broome County
  • Maks Danilin, Strategic Account Executive, Aware Recovery Care, Inc.
  • Mark A. Refowitz, Former Director, County of Orange Health Care Agency & Former Board Chairman, Cal Optima
  • Mary McClimon, Senior Vice President and Chief Administrative Officer, Heritage Behavioral Health Center
  • Matthew O. Hurford, M.D., Chief Medical Officer, Community Care Behavioral Health Organization
  • Melissa Larkin-Skinner, MBA, MA, LMHC, Chief Executive Officer, Centerstone of Florida
  • Melissa Norris, BA, Executive Director, Psychamerica Behavioral Services, LLC / Big Bear Behavioral Health, Inc.
  • Monica Collins, Sr. Director, System Transformation, Magellan Behavioral Health of Pennsylvania
  • Paul Duck, Vice President, Strategy & Development, Beacon Health Options
  • Ravi Ganesan, President & CEO, Core Solutions, Inc.
  • Rebecca Plonsky, LICSW, Vice President of Development for Integrated Behavioral Health-East and Southwest Region, Prospect CharterCARE, LLC
  • Rena Sheehan, Director, Behavioral Health, Blue Cross & Blue Shield of Rhode Island
  • Robert J. Budsock, MS, LCADC, President & CEO, Integrity House
  • Robert (Carl) Clark, MD, President & Chief Executive Officer, Mental Health Center of Denver
  • Stacey Carpenter, Psy.D., Director of Integrated Behavioral Health, The Family Practice & Counseling Network, a division of Resources for Human Development
  • Steven Sehr, MD, Medical Director, Behavioral Health, AmeriHealth Caritas Iowa
  • Sue Ann Atkerson, MA, LPC, Chief Operations Officer, RI International
  • Tim Macken, Chief Operating Officer, Heritage Behavioral Health Center
  • Tom Sebastian, MS, MPA, President & CEO, Compass Health

“For 2017, our focus is on helping organizations develop innovative collaborations and productive partnerships with the payers, health systems, and care management organizations that are driving the value-based care market,” said Monica E. Oss, chief executive officer of OPEN MINDS . “With increases in managed care and value-based contracting, and more focus on integration and care coordination, the traditional roles of health plans and provider organizations are changing. Our goal is to focus on helping these organizations uncover ‘what works’ – strategies that leverage emerging innovations and productive collaborations for success in this area of value-based care.”

Early registration is recommended, as seating is limited, and the event has sold out in the past. Register today at https://strategy.openminds.com/register/ .

OPEN MINDS is a national strategic advisory firm specializing in the sectors of the health and human service industry serving individuals with complex support needs: mental health; addiction treatment; children and family services; intellectual and developmental disabilities; chronic disease management; long term care; social services; correctional health care; and juvenile justice.

Founded in 1987 and based in Gettysburg, Pennsylvania, the 75+ associates believe by providing the latest market intelligence and management best practices to organizations serving the health and social support needs of the most vulnerable consumers, those organizations will be better able to provide efficient and effective services. Learn more at www.openminds.com .

For additional questions and inquiries, please contact Sarah Threnhauser, Executive Vice President, OPEN MINDS at 717-334-1329 or sthrenhauser@openminds.com . And don’t forget to follow us on Twitter at @openmindscircle and follow our official institute hashtag #OMStrategy for live social media coverage of the event.

Sarah Threnhauser OPEN MINDS 7173341329 openminds@openminds.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 78

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 236

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 337

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 501

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 15

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 45

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 31

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 55

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 69

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading

Top 5 Most Recently Viewed Articles

BioSyent Inc. to Announce Q3 Financial Results This Month

Updated Category News Views 189

BioSyent Inc. to Announce Q3 Financial Results BioSyent Inc., a prominent player in the specialty pharmaceutical industry, is preparing to release its financial results for the third quarter and year-to-date period. This important announcement is scheduled for November 20, prior to the market opening. The report will cover the company's performance for the three and nine...

Continue Reading
Dr. Ryan Egeland Joins Solventum as Chief Medical Officer

Updated Category News Views 381

Solventum Welcomes Dr. Ryan Egeland as New CMO Solventum, a pioneering healthcare company, recently announced the appointment of Dr. Ryan Egeland, MD, as their Chief Medical Officer. In this significant role, Dr. Egeland will lead the Global Medical and Clinical Affairs team, amplifying clinician and patient voices within the organization. Fostering Collaboration and...

Continue Reading
MiningToken Revolutionizes Cryptocurrency With AI Power

Updated Category News Views 186

Introducing MiningToken's Innovative AI Cloud Mining Service Bitcoin and Ethereum are experiencing remarkable market dynamics as Bitcoin persists in a bullish trend and Ethereum has gained notable ground recently. As global interest in cryptocurrencies grows, effective mining strategies are crucial for profitability. Amidst rising operational costs, many individuals seek...

Continue Reading
Saluda Medical's EVA™ Sensing Technology Approved in Europe

Updated Category News Views 111

Saluda Medical Achieves Regulatory Milestone with EVA™ Technology Saluda Medical, Inc. (ASX:SLD) has made significant strides in the medical device industry by achieving CE certification for its next-generation EVA™ Sensing Technology. This advancement not only marks a major endorsement in Europe but also is recognized in Australia. Following FDA approval in December...

Continue Reading
ReadPartner Inc. Unveils Revolutionary AI Tool to Combat Misinformation

Updated Category News Views 291

ReadPartner Inc. Launches AI Feature to Tackle Misinformation ReadPartner Inc., a leader in AI-driven media intelligence solutions, is excited to announce the upcoming launch of a groundbreaking digital security feature named ProfileScreen. This innovative tool aims to address the pressing issue of misinformation that plagues social media platforms. The ProfileScreen...

Continue Reading